Such conclusions are strongly supported by the large randomized trials of prostate cancer screening using the serum PSA test, that is, the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the American Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. The gene discussed is KLK3; the disease is prostate carcinoma.